title: Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype.
abstract: Metastatic melanoma is an aggressive skin cancer associated with poor prognosis. The reactivation of the embryonic morphogen Nodal in metastatic melanoma has previously been shown to regulate the aggressive behavior of these tumor cells. During the establishment of left-right asymmetry in early vertebrate development, Nodal expression is specifically regulated by a Notch signaling pathway. We hypothesize that a similar relationship between Notch and Nodal may be reestablished in melanoma. In this study, we investigate whether cross talk between the Notch and Nodal pathways can explain the reactivation of Nodal in aggressive metastatic melanoma cells. We show a molecular link between Notch and Nodal signaling in the aggressive melanoma cell line MV3 via the activity of an RBPJ-dependent Nodal enhancer element. We show a precise correlation between Notch4 and Nodal expression in multiple aggressive cell lines but not poorly aggressive cell lines. Surprisingly, Notch4 is specifically required for expression of Nodal in aggressive cells and plays a vital role both in the balance of cell growth and in the regulation of the aggressive phenotype. In addition, Notch4 function in vasculogenic mimicry and anchorage-independent growth in vitro is due in part to Notch4 regulation of Nodal. This study identifies an important role for cross talk between Notch4 and Nodal in metastatic melanoma, placing Notch4 upstream of Nodal, and offers a potential molecular target for melanoma therapy.
authors.affiliation: Program in Cancer Biology and Epigenomics, Children's Memorial Research Center, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL 60614, USA.
authors.forename: Katharine M
authors.initials: KM
authors.lastname: Hardy
authors.forename: Dawn A
authors.initials: DA
authors.lastname: Kirschmann
authors.forename: Elisabeth A
authors.initials: EA
authors.lastname: Seftor
authors.forename: Naira V
authors.initials: NV
authors.lastname: Margaryan
authors.forename: Lynne-Marie
authors.initials: LM
authors.lastname: Postovit
authors.forename: Luigi
authors.initials: L
authors.lastname: Strizzi
authors.forename: Mary J C
authors.initials: MJ
authors.lastname: Hendrix
mesh_terms: D017209:Apoptosis / Q000502:physiology; D048708:Cell Growth Processes / Q000502:physiology; D045744:Cell Line, Tumor; D006801:Humans; D008545:Melanoma / Q000098:blood supply / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000473:pathology; D055457:Nodal Protein / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D011518:Proto-Oncogene Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000378:metabolism*; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000235:genetics; D020239:Receptor Cross-Talk; D000074562:Receptor, Notch4; D051880:Receptors, Notch / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000378:metabolism*; D015398:Signal Transduction; D014162:Transfection
chemical_list: C526007:NODAL protein, human; C106075:NOTCH4 protein, human; D055457:Nodal Protein; D011518:Proto-Oncogene Proteins; D034741:RNA, Small Interfering; D000074562:Receptor, Notch4; D051880:Receptors, Notch